Adolescent extra-truncal progressive macular hypomelanosis.

Publisher: Wiley Country of Publication: United States NLM ID: 8406799 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1470 (Electronic) Linking ISSN: 07368046 NLM ISO Abbreviation: Pediatr Dermatol Subsets: MEDLINE

Publication: <2010->: Hoboken, NJ : Wiley
Original Publication: [Boston, MA] : Blackwell Scientific Publications, [1983-

Hypopigmentation*/diagnosis ; Hypopigmentation*/drug therapy ; Hypopigmentation*/pathology ; Anti-Infective Agents*; Female ; Humans ; Biopsy

Two adolescent females presented to outpatient clinic with isolated, non-scaly, asymptomatic hypopigmented macules and patches on the arm(s). Both cases had Wood's lamp exams notable for extralesional punctiform coral-red perifollicular fluorescence on the back and faint intralesional enhancement. In one case, biopsy was performed and deemed consistent with progressive macular hypomelanosis. The patient had complete response to antimicrobial therapy and sun exposure.
(© 2023 Wiley Periodicals LLC.)

Guillet G, Helenon R, Gauthier Y, Surleve-Bazeille J, Plantin P, Sassolas B. Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol. 1988;15(5):286-289. doi:10.1111/j.1600-0560.1988.tb00561.x.
Elmariah SB, Kundu RV. Progressive macular hypomelanosis. J Drugs Dermatol. 2011;10(5):502-506.
Hwang S, Hong S, Kim S, et al. Progressive macular hypomelanosis in korean patients: a clinicopathologic study. Ann Dermatol. 2009;21(3):261-267. doi:10.5021/ad.2009.21.3.261.
Relyveld GN, Menke HE, Westerhof W. Progressive macular hypomelanosis: an overview. Am J Clin Dermatol. 2007;8(1):13-19. doi:10.2165/00128071-200708010-00002.
McDowell AA-O, McLaughlin J, Layton AM. Is Cutibacterium (previously Propionibacterium) acnes a potential pathogenic factor in the aetiology of the skin disease progressive macular hypomelanosis? J Eur Acad Dermatol. 2020;35(2):338-344. doi:10.1111/jdv.16789.
Westerhof W, Relyveld G, Kingswijk M, Man P, Menke H. Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol. 2004;140(2):210-214. doi:10.1001/archderm.140.2.210.
Kumarasinghe SPW, Tan SH, Thng S, Thamboo TP, Liang S, Lee YS. Progressive macular hypomelanosis in Singapore: a clinico-pathological study. Int J Dermatol. 2006;45(6):737-742. doi:10.1111/j.1365-4632.2006.02755.x.
Selim M, Selim E, Abdelgawad M, El-Kamel M. Progressive macular hypomelanosis among Egyptian patients: a clinicopathological study. Dermatol Pract Concept. 2011;1(1):5-11. doi:10.5826/dpc.0101a03.
Neynaber SKC, Kamann S, Plewig G, Flaig MJ. Progressive macular hypomelanosis: a rarely diagnosed hypopigmentation in Caucasians. Dermatol Res Pract. 2009;2009:607682. doi:10.1155/2009/607682.
Wang K, Nassef Y, Sahu J, Hermes H, Schwartz LR. Facial involvement in progressive macular hypomelanosis. Cutis. 2018;101(4):297-300.
Wen L, Wang T, Yang C, Yang S, Cui Y, Zhang X. Progressive macular hypomelanosis with asymmetrically distributed lesions. Chin Med J. 2013;126(18):3591.
Thng S, Long V, Chuah S, Tan VW. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis. Indian J Dermatol Venereol Leprol. 2016;82(6):673-676. doi:10.4103/0378-6323.182797.
Leonard N, Krueger S, Rashighi M. Successful treatment of progressive macular hypomelanosis. Dermatol Rep. 2020;12(2):8509. doi:10.4081/dr.2020.8509.

Keywords: adolescent; case reports; hypopigmentation*/diagnosis; hypopigmentation*/drug therapy; hypopigmentation*/etiology

0 (Anti-Infective Agents)

Date Created: 20230206 Date Completed: 20230717 Latest Revision: 20230718

20230718

10.1111/pde.15252

36744793